Posted in

Is Intrauterine Manipulator Use Safe for Endometrial Cancer?

Doctor studying a medical course online using a laptop between clinical shifts

Surgeons frequently debate the choice of tools for gynecologic oncology. Specifically, intrauterine manipulator safety remains a major concern during minimally invasive hysterectomy. A recent systematic review analyzed survival outcomes for over 10,000 patients. Therefore, this data provides critical insights for clinical practice. Researchers compared outcomes in patients with and without these devices. Consequently, they found a potential link to lower survival rates.

New Evidence for Intrauterine Manipulator Safety

The analysis included 12 studies published between 2013 and 2024. Most of these studies used a retrospective design. Notably, the researchers found that disease-free survival was lower with manipulator use. The hazard ratio reached 1.18, which is statistically significant. However, the effect on overall survival was much smaller. This association did not reach statistical significance in the pooled analysis.

Impact on Clinical Decision Making

Clinical practitioners in India must weigh these results carefully. Furthermore, most included studies carried a moderate to serious risk of bias. Only a few trials adjusted for factors like tumor histology. Consequently, surgeons should exercise caution when using these tools. Prospective trials are still necessary to provide definitive answers. Nevertheless, the current evidence suggests that avoiding manipulators might improve outcomes.

Frequently Asked Questions

Q1: Does using an intrauterine manipulator increase cancer recurrence?

The study indicates that manipulator use may decrease disease-free survival, which suggests a higher risk of recurrence.

Q2: Is the impact on overall survival significant?

No, the study found that the association with overall survival was marginal and did not reach statistical significance.

References

  1. Nagase Y et al. Survival Association of Intrauterine Manipulator Use During Minimally Invasive Hysterectomy for Endometrial Cancer: A Systematic Review and Meta-analysis. Obstet Gynecol. 2026 Apr 01. doi: 10.1097/AOG.0000000000006195. PMID: 41712940.
  2. Uccella S et al. Impact of intrauterine manipulator on oncologic outcomes in endometrial cancer: a systematic review. Am J Obstet Gynecol. 2022.
  3. Padilla-Iserte P et al. Impact of uterine manipulator on oncological outcomes in patients with endometrial cancer undergoing minimally invasive surgery. Am J Obstet Gynecol. 2021.